Home/Events/Upcoming Events/Invivoscribe to Exhibit at 25th EHA Annual Congress
EVENTS
VIRTUAL – June 11 – 14, 2020 | On Demand Until October 15th

Invivoscribe to Exhibit at 25th EHA Annual Congress

EVENTS
VIRTUAL – June 11 – 14, 2020 | On Demand Until October 15th

Invivoscribe to Exhibit at 25th EHA Annual Congress

Join us in the Virtual Edition of the 25th EHA Annual Congress: “Unfolding the future!” Visit our virtual exhibition to learn more about our portfolio and to speak with one of our experts.

Virtual Exhibit Information:

Date: June 11 – 14, 2020 | On Demand Until October 15th
Venue: Virtual
Booth Link: https://eha.6connex.eu/event/EHA2020/en-us#!/invivoscribe

Join Our Virtual Symposium

NGS-Based Clinical Assessment of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection
Thursday, June 11 | 7:15 pm – 8:45 pm CEST | 10:15 am PST | 1:15 pm EST

Incorporating NGS Methods for Routine Clonality Assessment and Disease Monitoring of Lymphoid Malignancies
Dr. Maria Arcila – Memorial Sloan Kettering Cancer Center, NY, United States

Clonality analysis with NGS is the new frontier in MRD detection
Prof. Sara Galimberti – University of Pisa, Department of Clinical and Experimental Medicine, Italy

Next Generation Analysis in CLL and Other Malignancies
Prof. Dr. Markus Tiemann – Institute for Hematopathology Hamburg, Germany

Join us in the Virtual Edition of the 25th EHA Annual Congress: “Unfolding the future!” Visit our virtual exhibition to learn more about our portfolio and to speak with one of our experts.

Virtual Exhibit Information:

Date: June 11 – 14, 2020 | On Demand Until October 15th
Venue: Virtual
Booth Link: https://eha.6connex.eu/event/EHA2020/en-us#!/invivoscribe

Join Our Virtual Symposium

NGS-Based Clinical Assessment of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection
Thursday, June 11 | 7:15 pm – 8:45 pm CEST | 10:15 am PST | 1:15 pm EST

Incorporating NGS Methods for Routine Clonality Assessment and Disease Monitoring of Lymphoid Malignancies
Dr. Maria Arcila – Memorial Sloan Kettering Cancer Center, NY, United States

Clonality analysis with NGS is the new frontier in MRD detection
Prof. Sara Galimberti – University of Pisa, Department of Clinical and Experimental Medicine, Italy

Next Generation Analysis in CLL and Other Malignancies
Prof. Dr. Markus Tiemann – Institute for Hematopathology Hamburg, Germany

SHARE THIS EVENT
UPCOMING

Invivoscribe Events

UPCOMING

Invivoscribe Events

2020-05-27T18:11:58+00:00